Senior insider sale
See Remarks at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$2.36M
214.26K shares
What this filing means
KIRN DAVID plans to sell 214.26K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $2.36M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001958244-26-000477
DirectorOfficer10% Owner· See Remarks
Since Dec 2020
214.26K
Shares to sell
$2.36M
Approx. market value
26.84K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Acquired from issuer in private transaction
None
12/15/2020
26.84KTotal acquired26.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2020 | Acquired from issuer in private transaction None | 26.84K | — |
| Total | 26.84K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
12.41K
Market value
$124.7K
8/3/2026
—Completed
Units to sell
15.72K
Market value
$189.2K
7/10/2026
—Completed
Units to sell
42.61K
Market value
$548.2K
7/9/2026
—Completed
Units to sell
114.75K
Market value
$1.20M
6/22/2026
—Completed
Units to sell
1.92K
Market value
$19.3K
6/1/2026
Planned — Approximate Date
NASDPlanned
Units to sell
26.84K
Market value
$275.4K
8/4/2026
Total
Units
214.26K
Value
$2.36M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 12.41K | $124.7K | — | Completed |
7/10/2026 | 15.72K | $189.2K | — | Completed |
7/9/2026 | 42.61K | $548.2K | — | Completed |
6/22/2026 | 114.75K | $1.20M | — | Completed |
6/1/2026 | 1.92K | $19.3K | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 26.84K | $275.4K | NASD | Planned |
| Total | 214.26K | $2.36M | ||